Skip to Content
Merck

LC/MS Analysis of Opioid Glucuronide Metabolites in Urine on Ascentis® Express F5 after Solid Phase Extraction (SPE) using Supel-Select HLB

LC/MS Analysis of Opioid Glucuronide Metabolites in Urine on Ascentis® Express F5 after Solid Phase Extraction (SPE) using Supel™-Select HLB application for SPE, application for HPLC

Materials

analytical column

Product No.
Description
Pricing

Ascentis® Express F5, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 10 cm × 2.1 mm

standard

Product No.
Description
Pricing

Morphine-3-β-D-glucuronide solution

1 mg/mL in methanol with 0.05% NaOH, ampule of 1 mL, certified reference material, Cerilliant®

Hydromorphone solution

1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Buprenorphine glucuronide solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Buprenorphine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Codeine solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Codeine-6-β-D-glucuronide solution

100 μg/mL in methanol: water (2:8), ampule of 1 mL, certified reference material, Cerilliant®

Hydrocodone solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Hydromorphone-3-β-D-glucuronide

100 μg/mL in methanol: water (1:1), ampule of 1 mL, certified reference material, Cerilliant®

Morphine solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Norbuprenorphine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Oxycodone solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Oxymorphone-D3 solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Oxymorphone-3-β-D-glucuronide solution

100 μg/mL in methanol: water (1:1), ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

sample preparation

Solid Phase Extraction

sample/matrix

urine spiked with drugs and metabolites at 300 ng/mL

SPE well plate

Supel-Select HLB 96-well plate, 60 mg/well (575662-U)

condition

1 mL methanol followed by 1 mL water

sample addition

1 mL hydrolyzed urine

washing

1 mL water followed by 1 mL 25% methanol

elution

1 mL acetonitrile

column

Ascentis Express F5, 10 cm x 2.1 mm I.D., 2.7 μm particles (53569-U)

mobile phase

[A] 5 mM ammonium formate, pH 4.2 (adjusted with formic acid); [B] 5 mM ammonium formate in (95:5 acetonitrile:water) pH 5.2 (adjusted with formic acid)

gradient

15% B held for 1 min, to 70% B in 2 min, held at 70% B for 7 min

flow rate

0.4 mL/min

column temp.

35 °C

detector

ESI(+) TOF, full scan, m/z 100-1000

injection

3 μL

sample

300 ng/mL

Description

Analysis Note

Sample pretreatment: β-glucuronidase hydrolysis
The workflow for the LC/MS analysis of native drugs and associated metabolites from urine is shown here. The convenient liquid form of beta-glucuronidase from Sigma was used for hydrolysis of the glucuronide metabolites. SPE using Supel-Select HLB yielded clean extracts. The Ascentis Express F5 columns gave highly efficient, well-resolved peaks and rapid separation. Ultra high purity LC-MS solvents and additives provided trouble-free operation, and Cerilliant CRMs gave reliable quantification.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Supel is a trademark of Sigma-Aldrich Co. LLC